P ediatric obesity has reached epidemic proportions in the United States, 1 and there are reports of greater discharge diagnosis of obesity-related complications such as diabetes, sleep apnea, and gallbladder disease and longer length of stay. 2 The origin of pediatric obesity is multifactorial and leads to numerous complications 3, 4 affecting inflammatory processes 5 as well as nutrient metabolism. [6] [7] [8] [9] As a result, current estimations of nutrition status [10] [11] [12] and requirements among obese patients remain unclear. [13] [14] [15] Recognizing that body mass index (BMI) may predict obesity-related complications even in adulthood, the Institute of Medicine (IOM) 16 and, more recently, the American Academy of Pediatrics (AAP) 4 recommend that the term obesity be used in children aged 2-20 years (BMI ≥95th percentile). Once obesity has been identified, the role of nutrition support is to prevent complications associated with the provision of enteral or parenteral feedings. Undernutrition may result in energy and protein deprivation, 17, 18 whereas overzealous nutrition support may result in hypophosphatemia, typically observed in refeeding syndrome, and hyperglycemia; all of these complications may affect morbidity and mortality risk. 19 Thus, neither undernutrition nor overnutrition can be recommended during hospitalization of the obese child.
Methods
The American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) consists of healthcare professionals representing the disciplines of medicine, nursing, pharmacy, dietetics, and nutrition science. The mission of A.S.P.E.N. is to improve patient care by advancing the science and practice of nutrition support therapy. A.S.P.E.N. vigorously works to support quality patient care, education, and research in the fields of nutrition and metabolic support in all healthcare settings. These clinical guidelines were developed under the guidance of the A.S.P.E.N. Board of Directors. Promotion of safe and effective patient care by nutrition support practitioners is a critical role of the A.S.P.E.N. organization. The A.S.P.E.N. Board of Directors has published clinical guidelines since 1986. [20] [21] [22] Starting in 2007, A.S.P.E.N. has revised these clinical guidelines on an ongoing basis by reviewing about 20% of the chapters each year in order to keep them as current as possible.
These A.S.P.E.N. clinical guidelines are general. They are based upon general conclusions of health professionals who, in developing such guidelines, have balanced potential benefits to be derived from a particular mode of medical therapy against certain risks inherent with such therapy. However, the professional judgment of the attending health professional is the primary component of quality medical care. Because guidelines cannot account for every variation in circumstances, the practitioner must always exercise professional judgment in their application. These clinical guidelines are intended to supplement, but not replace, professional training and judgment.
These clinical guidelines were created in accordance with the IOM recommendations as "systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific clinical circumstances." 23 These clinical guidelines are for use by healthcare professionals who provide nutrition support services and offer clinical advice for managing adult and pediatric patients in inpatient and outpatient (ambulatory, home, and specialized care) settings. The utility of the clinical guidelines is attested to by the frequent citation of this document in peer-reviewed publications and its frequent use by A.S.P.E.N. members and other healthcare professionals in clinical practice, academia, research, and industry. The guidelines inform professional clinical activities, serve as educational tools, and influence institutional practices and resource allocation. 24 These clinical guidelines are formatted to promote the ability of the end user of the document to understand the strength of the literature used to grade each recommendation. Each guideline recommendation is presented as a clinically applicable definitive statement of care and should help the reader make the best patient care decision. The best available literature was obtained and carefully reviewed. Chapter authors completed a thorough literature review using Medline, the Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and other appropriate reference sources. The results of the literature search and review formed the basis of an evidence-based approach to the clinical guidelines. Chapter editors work with the authors to ensure compliance with the authors' directives regarding content and format. The initial draft is reviewed internally to ensure consistency with the other A.S.P.E.N. Guidelines and Standards and reviewed externally (either by experts in the field within our organization or outside of our organization) for appropriateness of content. Finally, the draft is reviewed and approved by the A.S.P.E.N. Board of Directors.
The system used to categorize the level of evidence for each study or article used in the rationale of the guideline statement and to grade the guideline recommendation is outlined in Table 1 . 25 The grade of a guideline is based on the levels of evidence of the studies used to support the guideline. A randomized controlled trial (RCT), especially one that is double-blind in design, is considered to be the strongest level of evidence to support decisions regarding a therapeutic intervention in clinical medicine. 26 A systematic review (SR) is a specialized type of literature review that analyzes the results of several RCTs. A high-quality SR usually begins with a clinical question and a protocol that addresses the methods to answer this question. These methods usually state how the literature is identified and assessed for quality, what data are extracted, how they are analyzed, and whether there were any deviations from the protocol during the course of the study. In most instances, meta-analysis (MA), a mathematical tool to combine data from several sources, is used to analyze the data. However, not all SRs use MA. SR is considered among the most important level of evidence in the field of evidence-based There is no adequate evidence to assess the clinical outcomes of hypocaloric or hypercaloric feeding during hospitalization of obese children. Therefore, the goals for the provision of energy to the pediatric obese inpatient should be similar to their nonobese counterparts. E medicine. A level of I, the highest level, will be given to large RCTs where results are clear and the risk of alpha and beta error is low (well-powered). A level of II will be given to RCTs that include a relatively low number of patients or are at moderate to high risk for alpha and beta error (underpowered). Meta-analyses can be used to combine the results of studies to further clarify the overall outcome of these studies but will not be considered in the grading of the guideline. A level of III is given to cohort studies with contemporaneous controls and to validation studies, whereas cohort studies with historic controls will receive a level of IV. Case series, uncontrolled studies, and articles based on expert opinion alone will receive a level of V. Table 2 provides the entire set of guideline recommendations for nutrition support of hospitalized pediatric patients with obesity.
Practice Guidelines and Rationales

Practice Guidelines
1. BMI is the preferred practical method to screen children for obesity. (Grade: D)
Rationale. Although BMI (kg/m 2 ) does not directly measure body fat, it has been recognized as a useful predictor of adiposity and medical complications of obesity. BMI is a measure of relative weight rather than adiposity. 27 Tracking studies from childhood to adulthood provide the best available evidence to support the validity of BMI as a screening criterion for obesity in children and adolescents. 28 There is increasing evidence that ≥95th percentile on BMI for sex and age charts in childhood predicts adult BMI, obesity, adiposity, and mortality [29] [30] [31] [32] [33] [34] [35] [36] [37] (Table 3) ; however, more tracking (longitudinal) data are needed, especially on clinical risks associated with obesity. 10, 28 Although BMI is an adequate screening method for older children and at a group level, its strength as an indicator of adiposity decreases at younger ages (<13 years) and may vary by ethnicity and race. 10, 38 There is no current valid measure for children younger than 2 years 10,39-40 or for severe obesity at any age. 10, 38, [41] [42] [43] 2. Pediatric obese inpatients may be at increased nutrition risk. Testing for potential laboratory abnormalities is recommended for safety reasons (eg, fasting blood sample, including lipid profile, glucose, phosphorus, and complete blood count). (Grade: E)
Rationale. Although the prevalence of pediatric obesity (based on BMI ≥95th percentile) is elevated, studies of obesity prevalence and nutrition support outcomes among obese compared with nonobese children in the hospital setting have not been evaluated. Nevertheless, we believe that hospitalized pediatric patients should undergo nutrition screening to identify those who require formal nutrition assessment with development of a nutrition care plan. Obese children are at increased risk for anemia, [44] [45] low fat-soluble vitamins levels (such as vitamin D), 8 low vitamin B status, 9 hyperlipidemia, insulin resistance, and hyperglycemia. 6, 7, 10, 46, 47 The presence of the metabolic syndrome in children is not well defined and may not predict obesity in adulthood. 48 There is some evidence from adult studies that tight control of hyperglycemia may affect morbidity and mortality, and there are anecdotal reports of hypophosphatemia following glucose provision in long-term fasting. 49 3. When possible, energy requirements of obese hospitalized children should be assessed using indirect calorimetry rather than predictive equations.
(Grade: D)
Rationale. Resting energy expenditure (REE) varies with obesity status but is best explained by differences in lean body mass. The percentage of lean body mass for each additional kilogram of weight above ideal weight is highly variable. Therefore, the calculation of excess weight to estimate ideal body weight is imprecise. As there is no practical and valid tool to evaluate lean body mass in order to estimate ideal weight in hospitalized patients, assessment of REE using indirect calorimetry is an alternative to the imprecision of equations (Table 4) . 13 Foulkes-Davis tracking index determines probability that mean of the curves of 2 individuals (with repeated measures) selected at random will not cross over time. 
